News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive May 30, 2019 Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Global Healthcare Conference Archive May 14, 2019 Deciphera Pharmaceuticals, Inc. to Present at the UBS Global Healthcare Conference Archive May 9, 2019 Deciphera Pharmaceuticals, Inc. Announces First Quarter 2019 Financial Results Archive March 14, 2019 Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Year-end 2018 Financial Results Archive March 4, 2019 Deciphera Pharmaceuticals, Inc. Announces Retirement of Michael D. Taylor, Ph.D. Archive February 7, 2019 Deciphera Pharmaceuticals, Inc. to Present at the 1st Annual Guggenheim Healthcare Talks Idea Forum Oncology Day Archive January 3, 2019 Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Carboplatin in Patients with Advanced or Metastatic Solid Tumors Archive January 2, 2019 Deciphera Pharmaceuticals Announces Positive, Preliminary, Top-Line Clinical Data for the Ongoing Phase 1 Clinical Study with DCC-3014 and an Update on Future Development Plans Archive January 2, 2019 Deciphera Pharmaceuticals, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference Archive December 20, 2018 Deciphera Pharmaceuticals Initiates Pivotal Phase 3 Clinical Study of Ripretinib (DCC-2618) in Second-line Patients with Gastrointestinal Stromal Tumors (“INTRIGUE” Study)
Archive May 30, 2019 Deciphera Pharmaceuticals, Inc. to Present at the Jefferies Global Healthcare Conference
Archive May 14, 2019 Deciphera Pharmaceuticals, Inc. to Present at the UBS Global Healthcare Conference
Archive March 14, 2019 Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Year-end 2018 Financial Results
Archive March 4, 2019 Deciphera Pharmaceuticals, Inc. Announces Retirement of Michael D. Taylor, Ph.D.
Archive February 7, 2019 Deciphera Pharmaceuticals, Inc. to Present at the 1st Annual Guggenheim Healthcare Talks Idea Forum Oncology Day
Archive January 3, 2019 Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Carboplatin in Patients with Advanced or Metastatic Solid Tumors
Archive January 2, 2019 Deciphera Pharmaceuticals Announces Positive, Preliminary, Top-Line Clinical Data for the Ongoing Phase 1 Clinical Study with DCC-3014 and an Update on Future Development Plans
Archive January 2, 2019 Deciphera Pharmaceuticals, Inc. to Present at the 37th Annual J.P. Morgan Healthcare Conference
Archive December 20, 2018 Deciphera Pharmaceuticals Initiates Pivotal Phase 3 Clinical Study of Ripretinib (DCC-2618) in Second-line Patients with Gastrointestinal Stromal Tumors (“INTRIGUE” Study)
